**Patient Discharge Summary**

**Patient Information:**

* Name: Jane Doe
* Date of Birth: February 12, 1985
* Admit Date: March 10, 2023
* Discharge Date: March 17, 2023
* Admission Diagnosis: Suspected Influenza with Respiratory Symptoms
* Age: 38 years

**Clinical Course:**

Jane Doe, a 38-year-old female, was admitted to the Infectious Diseases Unit on March 10, 2023, with a 3-day history of fever, cough, and sore throat. She presented with a temperature of 38.5°C (101.3°F), tachycardia of 110 beats per minute, and tachypnea of 24 breaths per minute. Her respiratory examination revealed bilateral wheezes and rhonchi. Laboratory tests revealed a white blood cell count of 12,000 cells/μL, with 60% neutrophils and 30% lymphocytes. Her chest x-ray demonstrated interstitial infiltrates consistent with primary influenza pneumonia.

**Diagnostic Evaluation:**

On March 11, 2023, a nasopharyngeal swab was collected for rapid antigen testing and RT-PCR testing. The rapid antigen test was negative, while the RT-PCR test was positive for influenza A (H3N2) virus. The patient was diagnosed with influenza A (H3N2) pneumonia.

**Treatment:**

Based on the patient's diagnosis and high-risk status, antiviral therapy was initiated. She was prescribed Oseltamivir 75 mg orally twice a day, starting on March 11, 2023. In addition, she received supportive care, including rest, hydration, and antipyretics, as well as pulse oximetry monitoring to detect hypoxemia.

**Medications:**

* Oseltamivir 75 mg orally twice a day, starting on March 11, 2023
* Ibuprofen 400 mg orally every 6 hours as needed for fever and pain relief
* Acetaminophen 325 mg orally every 4 hours as needed for fever and pain relief
* Hydrocodone 5 mg/acetaminophen 325 mg orally every 4-6 hours as needed for cough and pain relief

**Course of Hospitalization:**

The patient's fever resolved on March 13, 2023, and her respiratory symptoms improved significantly. She was gradually weaned off oxygen therapy on March 15, 2023. Her chest x-ray on March 16, 2023, showed significant improvement in her lung infiltrates. She was discharged from the hospital on March 17, 2023, in stable condition.

**Discharge Instructions:**

* Continue Oseltamivir 75 mg orally twice a day for 5 days
* Take Ibuprofen 400 mg orally every 6 hours as needed for fever and pain relief
* Take Acetaminophen 325 mg orally every 4 hours as needed for fever and pain relief
* Rest and avoid strenuous activities for 7-10 days
* Monitor for signs of complications, such as pneumonia or otitis media
* Follow up with primary care physician in 1-2 weeks for post-discharge evaluation

**Additional Information:**

The patient's family members were educated on infection control measures, including proper hand hygiene and respiratory etiquette, to prevent transmission of the virus.

**Conclusion:**

Jane Doe was successfully treated for influenza A (H3N2) pneumonia with antiviral therapy and supportive care. She was discharged from the hospital in stable condition, with instructions for continued antiviral therapy and post-discharge follow-up.